Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives
1. Nexalin appoints Justin Van Fleet as CFO effective August 1, 2025. 2. Van Fleet has over 20 years of experience in public accounting. 3. Nexalin aims to scale operations and advance neurostimulation platform. 4. FDA approval for Nexalin's devices could revolutionize mental health treatment. 5. New CFO's expertise expected to enhance financial transparency and strategy.